Cargando…

Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism

As classical agonists for peroxisomal proliferator-activated receptor alpha (PPARα), fibrates activate renal fatty acid metabolism (FAM) and provide renoprotection. However, fibrate prescription is limited in patients with kidney disease, since impaired urinary excretion of the drug causes serious a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aomura, Daiki, Harada, Makoto, Yamada, Yosuke, Nakajima, Takero, Hashimoto, Koji, Tanaka, Naoki, Kamijo, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230306/ https://www.ncbi.nlm.nih.gov/pubmed/34207854 http://dx.doi.org/10.3390/metabo11060372

Ejemplares similares

Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study
por: Harada, Makoto, et al.
Publicado: (2022)

Hospital Admission to a Window-Side Bed Does Not Prevent Delirium: A Retrospective Cohort Study of Older Medical Inpatients in General Wards
por: Aomura, Daiki, et al.
Publicado: (2021)

A Case of Acute Kidney Injury in a Patient with Renal Hypouricemia without Intense Exercise
por: Aomura, Daiki, et al.
Publicado: (2020)

Brain MRI detection of early Wernicke’s encephalopathy in a hemodialysis patient
por: Aomura, Daiki, et al.
Publicado: (2022)

Fatty Acid Accumulation and Resulting PPARα Activation in Fibroblasts due to Trifunctional Protein Deficiency
por: Wakabayashi, Masato, et al.
Publicado: (2012)

Predictive Factors of Cytomegalovirus Viremia during the Clinical Course of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Single Center Observational Study
por: Harada, Makoto, et al.
Publicado: (2023)

Anti-SARS-CoV-2 IgG antibody titer after BNT162b2 mRNA COVID-19 vaccination in Japanese patients who underwent renal replacement therapy, hemodialysis, peritoneal dialysis, and kidney transplantation
por: Iwabuchi, Ryohei, et al.
Publicado: (2023)

PPARα Activation Protects against Anti-Thy1 Nephritis by Suppressing Glomerular NF-κB Signaling
por: Hashimoto, Koji, et al.
Publicado: (2012)

Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study
por: Yamaguchi, Akinori, et al.
Publicado: (2017)

Clinically Relevant Dose of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα), Lowers Serum Triglyceride Levels by Targeting Hepatic PPARα in Mice
por: Zhang, Zhe, et al.
Publicado: (2022)

Impact of a change in vascular access flow volume after percutaneous transluminal angioplasty on cardiac function
por: Hashimoto, Koji, et al.
Publicado: (2021)

Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2011)

Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver disease
por: Shinozaki, Satoshi, et al.
Publicado: (2020)

Combination Therapy Using Pemafibrate and Dapagliflozin for Metabolic Dysfunction-associated Fatty Liver Disease
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
por: Sugimoto, Ryosuke, et al.
Publicado: (2023)

Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis
por: Yamada, Yosuke, et al.
Publicado: (2021)

Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut
por: Kunisawa, Jun, et al.
Publicado: (2015)

Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy
por: Lee, Su Mi, et al.
Publicado: (2015)

Lipids, fatty acids and hydroxy-fatty acids of Euphausia pacifica
por: Yamada, Hidetoshi, et al.
Publicado: (2017)

Repeated restraint stress modifies fatty acid and amino acid metabolism in the mouse skin
por: KITAGAWA, Yume, et al.
Publicado: (2022)

Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis †
por: Yamashita, Shizuya, et al.
Publicado: (2023)

A Case of an Elderly Woman Who Developed Corneal Perforation in the Clinical Course of Myeloperoxidase Positive Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Kobayashi, Shuhei, et al.
Publicado: (2023)

Omega-3 fatty acid prevents the development of heart failure by changing fatty acid composition in the heart
por: Toko, Haruhiro, et al.
Publicado: (2020)

Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation
por: Kasubuchi, Mayu, et al.
Publicado: (2015)

Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sjögren's Syndrome and Primary Hypothyroidism
por: Okumura, Taiki, et al.
Publicado: (2019)

Urinary liver-type fatty acid binding protein and chronic kidney disease
por: Kamijo-Ikemori, A., et al.
Publicado: (2015)

Omega-3 Polyunsaturated Fatty Acids for the Treatment of IgA Nephropathy
por: Hirahashi, Junichi
Publicado: (2017)

Pemafibrate therapy for non-alcoholic fatty liver disease is more effective in lean patients than obese patients
por: Shinozaki, Satoshi, et al.
Publicado: (2022)

Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
por: Ueno, Yuji, et al.
Publicado: (2019)

Potential Role of Free Fatty Acids in the Pathogenesis of Periodontitis and Primary Sjögren’s Syndrome
por: Shikama, Yosuke, et al.
Publicado: (2017)

Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats
por: Tanabe, Jun, et al.
Publicado: (2020)

Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2015)

Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate
por: Honda, Akihiro, et al.
Publicado: (2022)

Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐aspartate aminotransferase score
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

Fatty Acid Desaturases, Polyunsaturated Fatty Acid Regulation, and Biotechnological Advances
por: Lee, Je Min, et al.
Publicado: (2016)

Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors
por: Falomir-Lockhart, Lisandro Jorge, et al.
Publicado: (2019)

Omega 3 Fatty Acids vs Omega 6 Fatty Acids
por: Feliu, María, et al.
Publicado: (2022)

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
por: Morishita, Asahiro, et al.
Publicado: (2022)

Inhibitory Effects of Short-Chain Fatty Acids and ω-3 Polyunsaturated Fatty Acids on Profibrotic Factors in Dermal Fibroblasts
por: Maeshige, Noriaki, et al.
Publicado: (2019)

Warming Decreases Bioconversion of Polyunsaturated Fatty Acids in Chironomid Larvae Maintained on Cyanobacterium Microcystis
por: Strandberg, Ursula, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_has0k2ke3ih54jsdift2nm36mg